NCT02660710View on ClinicalTrials.gov

Rituximab Plus CHOP Chemotherapy for Diffuse Large B-cell Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

July 22, 2021

Study Completion Date

July 22, 2022

Conditions
Diffuse Large B-cell LymphomaHIV
Interventions
DRUG

R-CHOP

maximum of 6-8 cycles of R-CHOP over 18-24 weeks

Trial Locations (1)

Unknown

UNC Project, Lighthouse Trust, Lilongwe

All Listed Sponsors
collaborator

Fogarty International Center of the National Institute of Health

NIH

collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Cancer Institute (NCI)

NIH

lead

UNC Lineberger Comprehensive Cancer Center

OTHER

NCT02660710 - Rituximab Plus CHOP Chemotherapy for Diffuse Large B-cell Lymphoma | Biotech Hunter | Biotech Hunter